Africa Coronavirus Health South Africa

Pfizer has offered South Africa discounted Covid-19 vaccines

Pfizer Inc. and BioNTech SE offered to supply South Africa with their Covid-19 vaccine at a discounted US$10 a dose, yet the president’s office still described the cost as prohibitive, according to a person familiar with the talks.

The price was worked out according to South Africa’s status as a middle-income nation and is about half of what the drugmakers are charging in the U.S., the person said, asking not to be identified as the information hasn’t been made public. The fact that the companies are running a vaccine trial in the country was also taken into consideration, the person said.

Also read: Meet Nigerian Doctor behind Pfizer’s Covid-19 vaccine

A spokeswoman for South Africa’s Department of Health said the ministry can’t comment on the pricing as a deal is yet to be concluded. Representatives for Pfizer and BioNTech in Europe declined to comment on the ongoing talks, though said they are “firmly committed to equitable and affordable access for Covid-19 vaccines for people around the world, including South Africa”.

South Africa’s government is coming under mounting pressure from its labor-union allies, opposition parties and medical professionals over its failure to secure any bilateral vaccine-supply agreements with pharmaceutical companies. While at least 29 countries have already begun inoculating their populations, South Africa only expects to start getting shots for about 10% of its population in the second quarter. That deal has been arranged through the Covax initiative, which is designed to ensure poorer countries can secure access.

Source: Bloomberg

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: